Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-28

Clinical Trial Update: Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial update on tau imaging in progressive supranuclear palsy and corticobasal degeneration, with healthy volunteers; study completed and results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tau imaging agent (Avid Radiopharmaceuticals study)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Progressive Supranuclear Palsy, Corticobasal Degeneration | Phase 1 | Status: COMPLETED | Results posted: 2020-08-28